BIOMILQ, Inc. Secures $21 Million to Further Its Mission to Produce Sustainable, Commercial Lab-Grown Breastmilk

North Carolina-based mammary biotechnology company BIOMILQ, Inc., proudly announces the successful close of $21 million in Series A financing, which will enable their acceleration of bringing cell-cultured human milk to market. Leading the fundraise are Danish life science investor Novo Holdings and clean tech leader Breakthrough Energy Ventures. Additional support comes from Blue Horizon, Spero Ventures, Digitalis Ventures, Green Generation Fund, Alexandria and Gaingels.

BIOMILQ’s Co-Founders: Michelle Egger and Leila Strickland, PhD
BIOMILQ’s Team Celebrates New Lab’s Grand Opening, Sept. 2021

Unlocking human potential with breakthrough mammary biotechnology.